Document is current

Any future updates will be listed below

1409 Autoimmune disease and immunosuppressive therapy in relapsed long-term breast cancer survivors treated with cyclin-dependent kinase inhibitors and human epidermal receptor-2 monoclonal antibodies

Crossref DOI link: https://doi.org/10.1136/jitc-2023-SITC2023.1409

Published Online: 2023-11-02

Published Print: 2023-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark